We use cookies to make your experience better. To comply with the new e-Privacy directive, we need to ask for your consent to set the cookies. Learn more.
GSD NovaType III SARS-CoV-2 (1x96 reactions)
CE-IVD marked Multiplex RT-PCR Assay for the qualitative detection and discrimination of relevant mutations associated with SARS-CoV-2 variants: B.1.427 / B.1.429 (Epsilon), / B.1.617.2 (Delta), B.1.617.1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
The assay is intended as a confirmatory test for detection of concerning RNA mutations within the S gene of the SARS-CoV-2 genome that are suspected to affect efficacy of vaccination or transmissibility of the virus.
Not available in the US.
CE-IVD marked Multiplex RT-PCR Assay for the qualitative detection and discrimination of relevant mutations associated with SARS-CoV-2 variants: B.1.427 / B.1.429 (Epsilon), / B.1.617.2 (Delta), B.1.617.1 (Kappa) / B.1.617.3, B.1.351 (Beta) / P.1 (Gamma).
• Confirmatory test for detection of new emerging mutations
• Parallel discrimination between S gene 484 wildtype (E484) and mutations E484K, E484Q, and L452R
• Specimen types: nasal lavage/smear, nasopharyngeal lavage/smear, oropharyngeal swab
• Validated PCR platforms: AriaMxTM and AriaDxTM (Agilent Technologies); additional thermal cyclers currently under validation
• Fast and reliable results with very high sensitivity
• CE-IVD
The assay is intended as a confirmatory test for detection of concerning RNA mutations within the S gene of the SARS-CoV-2 genome that are suspected to affect efficacy of vaccination or transmissibility of the virus and can be for example found in the following SARS-CoV-2 lineages:
Mutation | Lineages | First Detected | WHO label |
E484K |
B.1.351(20H/501Y.V2) |
South Africa Brazil |
Beta |
E484Q | B.1.617 (G/452.V3) | India | Delta |
L452R |
B.1.427 / B.1.429 (CAL.20C) |
USA India |
Epsilon Kappa |
Not available in the US.
SKU | PCOV6093T |
---|---|
No. of tests | 96 |
Specificity | Nasal lavage/smear, nasopharyngeal lavage/smear, oropharyngeal swab |
PCR cycler platforms | AriaMxTM and AriaDxTM (Agilent Technologies) |